Royalty PharmaRPRX 
$28.21-0.11%24h
-0.11%24h
Global rank
Market cap$12.63B
Change 7d-2.82%
YTD Performance0.79%
SP500 benchmarkUnderperform
P/E11.15
P/S5.36
Revenue$2.35B
Earnings$1.70B
Dividend yield2.8%
Main Sector
Healthcare
Royalty Pharma (RPRX) Cash on Hand
RPRX Cash on Hand in 2022: $1.23B
According to Royalty Pharma latest financial reports the cash on hand of RPRX is $1.23B, an decrease of -49.18% to 2022. At the end of 2022 company had $2.43B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
RPRX Cash on Hand History from 2018 to 2023
-
Value:-
RPRX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.23B | -49.18% |
| 2022 | $2.43B | -13.39% |
| 2021 | $2.80B | 5.82% |
| 2020 | $2.65B | 233.97% |
| 2019 | $793.21M | -66.76% |
| 2018 | $2.39B | - |
View the Top Cash on Hand Companies 
